Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CERE — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree CERE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CERE — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the Cerevel Therapeutics Holdings Insider Buying occurred are:

Rain Oncology Insider Buying
Know Labs Insider Buying
Stellus Capital Investment Insider Buying
Funko Insider Buying
MiNK Therapeutics Insider Buying
Sacks Parente Golf Insider Buying
Tango Therapeutics Insider Buying
Thorne Healthtech Insider Buying
Scholar Rock Holding Insider Buying
Black Diamond Therapeutics Insider Buying

Cerevel Therapeutics Holdings insider buying image
The table below summarizes the most recent Cerevel Therapeutics Holdings insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Cerevel Therapeutics Holdings insider buys are important for investors to follow.
DateInsiderPriceAmount
10-16-2023
Insider Buy		 BAIN CAPITAL INVESTORS LLC
>10% Owner		 $22.81
CAGR » 		$124,999,986.12
5,480,052 shares
10-16-2023
Insider Buy		 Adam Koppel
Director and >10% Owner		 $22.81
CAGR » 		$124,999,986.12
5,480,052 shares
10-16-2023
Insider Buy		 Christopher R. Gordon
Director and >10% Owner		 $22.81
CAGR » 		$124,999,986.12
5,480,052 shares
10-16-2023
Insider Buy		 PERCEPTIVE ADVISORS LLC
Director		 $22.81
CAGR » 		$19,999,990.48
876,808 shares
8-4-2023
Insider Buy		 Paul D. Burgess
See Remarks		 $22.93
CAGR » 		$501,793.73
21,880 shares
8-3-2023
Insider Buy		 Ronald C. Renaud Jr.
President & CEO		 $23.96
CAGR » 		$2,008,811.21
83,857 shares
8-16-2022
Insider Buy		 PERCEPTIVE ADVISORS LLC
Director		 $35.00
CAGR » 		$49,875,000.00
1,425,000 shares
8-26-2021
Insider Buy		 PERCEPTIVE ADVISORS LLC
Director		 $30.23
CAGR » 		$2,057,060.81
68,047 shares
8-25-2021
Insider Buy		 PERCEPTIVE ADVISORS LLC
Director		 $27.53
CAGR » 		$4,833,884.98
175,585 shares
7-7-2021
Insider Buy		 PERCEPTIVE ADVISORS LLC
Director		 $25.00
CAGR » 		$5,000,000.00
200,000 shares
6-17-2021
Insider Buy		 Gabrielle Sulzberger
Director		 $13.06
CAGR » 		$275,357.04
21,084 shares
11-9-2020
Insider Buy		 BAIN CAPITAL INVESTORS LLC
>10% Owner		 $10.30
CAGR » 		$3,422,617.90
332,293 shares
11-9-2020
Insider Buy		 Adam Koppel
Director and >10% Owner		 $10.30
CAGR » 		$3,422,617.90
332,293 shares
11-9-2020
Insider Buy		 Christopher R. Gordon
Director and >10% Owner		 $10.30
CAGR » 		$3,422,617.90
332,293 shares
11-9-2020
Insider Buy		 BAIN CAPITAL INVESTORS LLC
>10% Owner		 $10.30
CAGR » 		$3,422,617.90
332,293 shares
10-27-2020
Insider Buy		 Christopher R. Gordon
Director and >10% Owner		 $10.00
CAGR » 		$100,000,000.00
10,000,000 shares
10-27-2020
Insider Buy		 BAIN CAPITAL INVESTORS LLC
>10% Owner		 $10.00
CAGR » 		$100,000,000.00
10,000,000 shares
10-27-2020
Insider Buy		 Adam Koppel
Director and >10% Owner		 $10.00
CAGR » 		$100,000,000.00
10,000,000 shares
10-27-2020
Insider Buy		 PERCEPTIVE ADVISORS LLC
Director		 $10.00
CAGR » 		$30,000,000.00
3,000,000 shares
1-16-2013
Insider Buy		 Trust Ambergate
>10% Owner		 $4.61
CAGR » 		$197,488.13
42,880 shares
1-15-2013
Insider Buy		 Trust Ambergate
>10% Owner		 $4.69
CAGR » 		$615,114.55
131,264 shares
1-7-2013
Insider Buy		 Trust Ambergate
>10% Owner		 $4.11
CAGR » 		$1,093.10
266 shares
12-28-2012
Insider Buy		 Trust Ambergate
>10% Owner		 $4.16
CAGR » 		$114,322.44
27,500 shares
12-20-2012
Insider Buy		 Trust Ambergate
>10% Owner		 $3.89
CAGR » 		$381,250.25
98,090 shares
6-1-2012
Insider Buy		 Robert W. Carlson Jr.
 $9.94
CAGR » 		$94,385.00
9,500 shares
2-27-2012
Insider Buy		 Trust Ambergate
>10% Owner		 $13.00
CAGR » 		$1,999,998.00
153,846 shares
2-27-2012
Insider Buy		 Luxembourg S. A. Artal
>10% Owner		 $13.00
CAGR » 		$11,000,002.00
846,154 shares

Also See: Institutional Holders of CERE
Also See: SEC filings

CERE Performance Since Insider Purchase
Below we present the annualized performance delivered by Cerevel Therapeutics Holdings stock since 10-16-2023 (the date of the most recent insider purchase). The performance of the investment from the time Cerevel Therapeutics Holdings insider buying occurred is the ultimate test of whether insiders were right about CERE being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 10/17/2023
End date: 04/26/2024
Start price/share: $22.73
End price/share: $42.47
Dividends collected/share: $0.00
Total return: 86.85%
Annualized Gain: 165.10%
Starting investment: $10,000.00
Ending investment: $18,685.00
Years: 0.53

Cerevel Therapeutics Holdings Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Cerevel Therapeutics Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CERE

Cerevel Therapeutics Holdings Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.